این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Pharmaceutical Care، جلد ۱۰، شماره ۲، صفحات ۴۴-۴۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
چکیده انگلیسی مقاله Background: During the first wave of the COVID-19 pandemic, severe patients were treated with the off-label drugs hydroxychloroquine and lopinavir/ritonavir. The aim of the study was to determine the prevalence of potential drug-drug interactions (DDIs) between hydroxychloroquine, lopinavir/ritonavir and concomitant medications used by hospitalized patients treated for COVID-19 in Costa Rica.Methods: We included all patients that received lopinavir/ritonavir or hydroxychloroquine as treatment for COVID-19. Clinical pharmacists reviewed the prescription profile of each patient and determined the probability and severity of any DDI through two databases (The Lexi-Interact program) and the Micromedex online interaction checker. A logistic regression model was used to identify variables associated with the occurrence of potential DDIs.Results: We identified a total of 108 potential DDIs in 34 inpatients (n=34). At least one of these DDIs occurred in 27 patients (79.4%; 95% CI: 65.8-92.9%). A total of 70 DDIs (64.8%) were classified as clinically relevant (grade D or X) by the clinical pharmacists. Only the number of concomitant drugs was associated with the occurrence of a probable DDI. The most common drugs associated with any DDI were fentanyl (n=12, 11.1%), midazolam (n=11, 10.2%), and insulin (n=10, 10.2%).Conclusion: A large proportion of patients treated with hydroxychloroquine and lopinavir/ritonavir for severe COVID-19 were at risk for clinical meaningful DDIs.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Allan Ramos-Esquivel
Department of Pharmacology, School of Medicine, University of Costa Rica, Costa Rica.


| Cristina Fernández
Pharmacy Department, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, Costa Rica.


| Luis Garro-Zamora
Pharmacy Department, Hospital México, Caja Costarricense de Seguro Social, Costa Rica.


| Ana Chaves
Pharmacy Department, Hospital Rafael Ángel Calderón Guardia, Caja Costarricense de Seguro Social, Costa Rica.


| Álvaro Víquez-Jaikel
Pharmacy Department, Hospital San Juan de Dios, Caja Costarricense de Seguro Social, Costa Rica.
نشانی اینترنتی https://jpc.tums.ac.ir/index.php/jpc/article/view/476
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات